Acute coronary syndromes fibrinolytics

Formulate a monitoring plan for a patient with ST-segment elevation acute coronary syndrome receiving fibrinolytics, aspirin, unfractionated heparin, intravenous nitroglycerin, intravenous (3-blockers followed by oral P-blockers, an angiotensin-converting enzyme inhibitor, and a statin. 

Early reperfusion therapy with either primary percutaneous coronary intervention or administration of a fibrinolytic agent within 3 hours of symptom onset is the recommended therapy for patients presenting with ST-segment elevation acute coronary syndrome. 

Randomized comparison of direct thrombin inhibition versus heparin in conjunction with fibrinolytic therapy for acute myocardial infarction results from the GUSTO-lib Trial. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO-lib) Investigators. J Am Coll Cardiol, 1998.31(7) 1493-8. 

Since most patients with ST-elevation acute coronary syndrome have acutely occluded vessels (6), fibrinolytic... 

Figure 7.4 (A) A patient with thoracic pain due to a dissecting aortic aneurysm. An ST-segment elevation in V1-V3 can be explained by the mirror pattern of an evident LVE (V6) due to hypertension. This ST-segment elevation has been erroneously interpreted as due to an acute coronary syndrome. As a consequence, fibrinolytic...

---